The burgeoning role of global health diplomacy to alleviate suffering of cancer patients in low- and middle-income countries
Authors:
- Melissa AdomakoMAMelissa Adomako
- Alaei KamiarAKAlaei Kamiar
- Abdulla AlshaikhAAAbdulla Alshaikh
- Lyndsay S BainesLBLyndsay S Baines
- Desiree BensonDBDesiree Benson
- Douglas W BettcherDBDouglas W Bettcher
- Baljit CheemaBCBaljit Cheema
- Lex CorijnLCLex Corijn
- Evan FountainEFEvan Fountain
- Bartosz G GdaniecBGBartosz G Gdaniec
- Elan GaronzikEGElan Garonzik
- Mary HarneyMHMary Harney
Open Access
- 1 May 2020
- journal article
- editorial
- Published by Oxford University Press (OUP) in International Health
- Vol. 12 (3) , 231-233
Abstract
The science of global health diplomacy (GHD) consists of cross-disciplinary, multistakeholder credentials comprised of national security, public health, international affairs, management, law, economics and trade policy. GHD is well placed to bring about better and improved multilateral stakeholder leverage and outcomes in the prevention and control of cancer. It is important to create an evidence base that provides clear and specific guidance for health practitioners in low- and middle-income countries (LMICs) through involvement of all stakeholders. GHD can assist LMICs to negotiate across multilateral stakeholders to integrate prevention, treatment and palliative care of cancer into their commercial and trade policies.Keywords
This publication has 13 references indexed in Scilit:
- Cultural Sensitivity in Deployed US Medical PersonnelJAMA Surgery, 2018
- Microeconomic Benefit of Corneal Transplantation in a Developing Country via Public–Private Partnership ModelWorld Journal of Surgery, 2018
- Applied global health diplomacy: profile of health diplomats accredited to the UNITED STATES and foreign governmentsGlobalization and Health, 2018
- Global cancer control: responding to the growing burden, rising costs and inequalities in accessESMO Open, 2018
- Public-Private Partnership Model to Provide Humanitarian Services in Developing CountriesJournal of the American College of Surgeons, 2017
- Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd editionThe Lancet, 2016
- Global Pediatric Oncology: Lessons From Partnerships Between High-Income Countries and Low- to Mid-Income CountriesJournal of Clinical Oncology, 2016
- Expert panel slams WHO's poor showing against EbolaThe Lancet, 2015
- Global health diplomacy: the need for new perspectives, strategic approaches and skills in global health2007
- Reflections on the revolution in health and foreign policy2007